EUVIMEDEUVIMED entdecken
Vergleichsstudie

Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome

Hernan F Guillen-Burgos, Juan F Galvez-Florez, Sergio Moreno-López, Juan-Manuel Anaya, Angela T H Kwan, Roger S McIntyre

The Journal of Clinical Psychiatry · 2025

DOI: 10.4088/jcp.24m15387 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Hernan F Guillen-Burgos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Simón Bolívar, Centro de Investigaciones en Ciencias de la Vida, Center for Clinical and Translational Research, Barranquilla, Colombia. Hauptthemen laut MEDLINE: Vortioxetine, Major Depressive Disorder, Cognitive Dysfunction, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VortioxetineMajor Depressive DisorderCognitive DysfunctionCOVID-19Antidepressive AgentsHumansMaleFemaleMiddle AgedSertralineAdultEscitalopramCitalopramProspective StudiesTreatment OutcomePost-Acute COVID-19 SyndromeSARS-CoV-2

Substanzen

VortioxetineSertralineEscitalopramCitalopramAntidepressive Agents

Autor:innen und Institutionen

  • Universidad Simón Bolívar, Centro de Investigaciones en Ciencias de la Vida, Center for Clinical and Translational Research, Barranquilla, Colombia.
  • Universidad El Bosque, Faculty of Medicine, Center for Clinical and Translational Research, Bogotá, Colombia.
  • Pontificia Universidad Javeriana, Department of Psychiatry and Mental Health, Hospital Universitario San Ignacio, Bogotá, Colombia.
  • Corresponding Author: Hernan F. Guillen-Burgos, MD, Centro de Investigaciones en Ciencias de la Vida, Center for Clinical and Translational Research, Universidad Simón Bolívar, Carrera 54 # 64-22, Barranquilla, CO (hern…
  • Faculty of Medicine, Universidad de Los Andes, Bogotá, Colombia.
  • Universidad de la Costa, Faculty of Medicine, Barranquilla, Colombia.

Zitieren

APA

Guillen-Burgos, H. F., Galvez-Florez, J. F., Moreno-López, S., Anaya, J. M., Kwan, A. T. H., & McIntyre, R. S. (2025). Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.24m15387

Vancouver

Guillen-Burgos HF, Galvez-Florez JF, Moreno-López S, Anaya JM, Kwan ATH, McIntyre RS. Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.24m15387

BibTeX
@article{GuillenBurgos2025,
  author = {Guillen-Burgos, Hernan F and Galvez-Florez, Juan F and Moreno-López, Sergio and Anaya, Juan-Manuel and Kwan, Angela T H and McIntyre, Roger S},
  title = {Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome},
  journal = {The Journal of Clinical Psychiatry},
  year = {2025},
  doi = {10.4088/jcp.24m15387}
}
Kostenlos starten →